Latest News about ABBV
Recent news which mentions ABBV
Beat the Nasdaq With This Cash-Gushing Dividend Stock
October 23, 2024
From Motley Fool
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
October 23, 2024
From Motley Fool
3 Growth Stocks That Could Be Bargain Buys Right Now
October 18, 2024
From Motley Fool
From Benzinga
Market Analysis: AbbVie And Competitors In Biotechnology Industry
October 17, 2024
From Benzinga
From Benzinga
From Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
October 14, 2024
From Motley Fool
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
October 14, 2024
From Motley Fool
There Are Only 28 S&P 500 Companies Warren Buffett Can't Buy Outright. Here's the Best of the Bunch for Income Investors.
October 12, 2024
Tickers
ABBV
From Motley Fool
From Benzinga
AbbVie's Options: A Look at What the Big Money is Thinking
October 09, 2024
Tickers
ABBV
From Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
From Benzinga
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
October 07, 2024
Tickers
ABBV
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 07, 2024
From Benzinga
3 Magnificent Dividend Stocks to Buy in October
October 06, 2024
From Motley Fool
Tickers
ABBV
From Motley Fool
From Motley Fool
From Benzinga
Comparing AbbVie With Industry Competitors In Biotechnology Industry
October 03, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.